Request Free Sample ×

Kindly complete the form below to receive a free sample of this Report

* Please use a valid business email

Leading companies partner with us for data-driven Insights

clients tt-cursor

Autoimmune Disease Diagnostics Companies

ID: MRFR/HC/5252-HCR
200 Pages
Rahul Gotadki
Last Updated: February 16, 2025
Autoimmune Disease Diagnostics companies play a vital role in early disease detection. Specializing in research, development, and distribution, they provide cutting-edge diagnostic tools, contributing to timely and accurate identification of autoimmune diseases, crucial for effective management and treatment.
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Autoimmune Disease Diagnostics Market
Market Size
Forecast Period2025 - 2035
CAGR (2025 - 2035)6.72%
2024 Market Size$ 5.58 Billion
2025 Market Size$ 5.96 Billion
2035 Market Size$ 11.41 Billion
Key Players
Abbott Laboratories
Roche Diagnostics
Thermo Fisher Scientific
Siemens Healthineers
Bristol-Myers Squibb
Quest Diagnostics
Opportunities
  • Increased Awareness and Education
  • Government Initiatives and Funding
  • Growing Demand for Personalized Medicine

Top Industry Leaders in the Autoimmune Disease Diagnostics Market

Autoimmune Disease Diagnostics Market
ย 

Latestย Autoimmune Disease Diagnosticsย Companiesย Updates:

Mayo Clinic Laboratories and Progentec Diagnostics collaborate on advanced biomarker testing: This strategic partnership expands access to Progentec's AI-powered blood tests for proactive management of autoimmune diseases.

Siemens Healthineers partners with Icana Care to improve early diagnosis of autoimmune diseases: This collaboration focuses on integrating Icana Care's AI-powered platform with Siemens' imaging systems for faster and more accurate diagnosis.

Roche acquires Teneobio, a French AI startup developing early-stage diagnostics for autoimmune diseases: This acquisition strengthens Roche's commitment to personalized medicine and AI-driven diagnostics.

Quest Diagnostics launches new autoimmune panels for comprehensive disease evaluation: These panels offer a streamlined approach to testing for multiple autoimmune markers in one test.

Abbott introduces a new point-of-care test for rheumatoid arthritis (RA): This rapid test allows for on-site diagnosis and faster treatment initiation.

TheraTech Technologies receives FDA approval for its anti-phospholipid syndrome (APS) diagnostic test: This approval provides a new tool for diagnosing this often-misunderstood autoimmune condition.

List ofย Autoimmune Disease Diagnosticsย companies in the market:

  • Siemens Healthcare Private Limited
  • bioMรฉrieux SA
  • Bio-rad Laboratories
  • Beckman Coulter
  • AstraZeneca
  • EUROIMMUN AG
  • Hoffmann-la Roche
  • Inova Diagnostics
  • Myriad Genetics
  • Thermo Fisher Scientific
  • Trinity Biotech Plc.